Cas no 83164-31-2 (2-tert-butylindolizine-3-carbaldehyde)
2-tert-butylindolizine-3-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 2-tert-Butylindolizine-3-carboxaldehyde
- 2-tert-butylindolizine-3-carbaldehyde
- OR1975
- 2-(tert-Butyl)indolizine-3-carbaldehyde
- 2-(tert-Butyl)indolizine-3-carboxaldehyde
- 2-tert-Butyl-indolizine-3-carbaldehyde
- DTXSID30461221
- AKOS005254761
- 83164-31-2
- MFCD08056206
-
- MDL: MFCD08056206
- Inchi: 1S/C13H15NO/c1-13(2,3)11-8-10-6-4-5-7-14(10)12(11)9-15/h4-9H,1-3H3
- InChI Key: KEIBKRMCZZZUTD-UHFFFAOYSA-N
- SMILES: O=CC1=C(C=C2C=CC=CN12)C(C)(C)C
Computed Properties
- Exact Mass: 201.11500
- Monoisotopic Mass: 201.115364102g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 243
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4
- Topological Polar Surface Area: 21.5?2
Experimental Properties
- Density: 1.02
- Refractive Index: 1.547
- PSA: 21.48000
- LogP: 3.04930
2-tert-butylindolizine-3-carbaldehyde Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
2-tert-butylindolizine-3-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Matrix Scientific | 200363-1g |
2-tert-Butyl-indolizine-3-carbaldehyde |
83164-31-2 | 1g |
$348.00 | 2023-09-09 | ||
| Chemenu | CM241531-1g |
2-(tert-Butyl)indolizine-3-carbaldehyde |
83164-31-2 | 95%+ | 1g |
$419 | 2021-08-04 | |
| Apollo Scientific | OR1975-1g |
2-(tert-Butyl)indolizine-3-carboxaldehyde |
83164-31-2 | 1g |
£260.00 | 2023-09-02 | ||
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTQ3667-1 G |
2-tert-butylindolizine-3-carbaldehyde |
83164-31-2 | 95% | 1g |
¥ 2,560.00 | 2021-05-07 | |
| Chemenu | CM241531-1g |
2-(tert-Butyl)indolizine-3-carbaldehyde |
83164-31-2 | 95%+ | 1g |
$*** | 2023-05-29 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTQ3667-100.0mg |
2-tert-butylindolizine-3-carbaldehyde |
83164-31-2 | 95% | 100.0mg |
¥764.0000 | 2025-04-11 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTQ3667-250.0mg |
2-tert-butylindolizine-3-carbaldehyde |
83164-31-2 | 95% | 250.0mg |
¥1022.0000 | 2025-04-11 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTQ3667-500.0mg |
2-tert-butylindolizine-3-carbaldehyde |
83164-31-2 | 95% | 500.0mg |
¥1708.0000 | 2025-04-11 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTQ3667-1.0g |
2-tert-butylindolizine-3-carbaldehyde |
83164-31-2 | 95% | 1.0g |
¥2559.0000 | 2025-04-11 | |
| A2B Chem LLC | AC27510-1g |
2-(tert-Butyl)indolizine-3-carboxaldehyde |
83164-31-2 | 95+% | 1g |
$1280.00 | 2024-04-19 |
2-tert-butylindolizine-3-carbaldehyde Related Literature
-
Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
-
Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
-
H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
-
Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
-
José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
Additional information on 2-tert-butylindolizine-3-carbaldehyde
Introduction to 2-tert-butylindolizine-3-carbaldehyde (CAS No. 83164-31-2)
2-tert-butylindolizine-3-carbaldehyde, identified by its Chemical Abstracts Service (CAS) number 83164-31-2, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic aldehyde features a unique structural framework that has garnered considerable attention due to its potential applications in medicinal chemistry and synthetic methodologies. The presence of both a tert-butyl group and an aldehyde functionality within the indolizine core imparts distinct reactivity and electronic properties, making it a valuable intermediate in the synthesis of more complex molecules.
The indolizine scaffold, a bicyclic structure consisting of a benzene ring fused to a pyrrolidine ring, is well-documented for its role in various biologically active compounds. In particular, derivatives of indolizine have been explored for their pharmacological properties, including antimicrobial, anti-inflammatory, and neuroprotective effects. The introduction of the 2-tert-butylindolizine-3-carbaldehyde moiety into these studies has opened new avenues for drug discovery, particularly in the development of targeted therapies.
Recent advancements in the field have highlighted the utility of 2-tert-butylindolizine-3-carbaldehyde as a key intermediate in the synthesis of bioactive molecules. For instance, researchers have leveraged its aldehyde group to facilitate condensation reactions with various nucleophiles, leading to the formation of Schiff bases and other functionalized derivatives. These compounds have shown promise in modulating enzyme activity and receptor binding, thereby contributing to the development of novel therapeutic agents.
The tert-butyl group attached to the indolizine ring not only enhances the steric bulk of the molecule but also influences its electronic properties, making it more susceptible to certain types of chemical transformations. This characteristic has been exploited in catalytic processes where steric hindrance can be leveraged to control reaction outcomes. Additionally, the aldehyde functionality serves as a versatile handle for further functionalization, allowing chemists to tailor the molecule's properties for specific applications.
In the context of modern pharmaceutical research, 2-tert-butylindolizine-3-carbaldehyde has been incorporated into libraries of compounds designed for high-throughput screening. These libraries are used to identify lead compounds with desirable pharmacological profiles before further optimization. The compound's unique structural features make it an attractive candidate for such screens, as they may confer specificity against certain biological targets while minimizing off-target effects.
The synthesis of 2-tert-butylindolizine-3-carbaldehyde typically involves multi-step organic transformations starting from readily available precursors. One common approach involves the Friedel-Crafts acylation of an indolizine derivative followed by reduction and subsequent functionalization at the 3-position. Advances in synthetic methodologies have enabled more efficient and scalable production processes, which are essential for industrial applications.
From a computational chemistry perspective, 2-tert-butylindolizine-3-carbaldehyde has been studied to understand its electronic structure and reactivity. Molecular modeling techniques have provided insights into how the tert-butyl group and aldehyde moiety interact with each other and with potential biological targets. These studies have informed rational drug design strategies, allowing researchers to predict and optimize binding affinities more effectively.
The compound's potential extends beyond pharmaceutical applications into materials science and agrochemicals. For example, its structural motif has been explored as a building block for liquid crystals and organic semiconductors due to its rigid framework and tunable electronic properties. Additionally, derivatives of 2-tert-butylindolizine-3-carbaldehyde have shown promise as intermediates in the synthesis of crop protection agents.
Ethical considerations are paramount when handling 2-tert-butylindolizine-3-carbaldehyde, as with any chemical compound used in research or industrial settings. Proper handling procedures must be followed to ensure safety and environmental compliance. This includes storage under appropriate conditions, use of personal protective equipment (PPE), and adherence to waste disposal regulations.
In conclusion,2-tert-butylindolizine-3-carbaldehyde (CAS No. 83164-31-2) represents a fascinating compound with diverse applications in chemistry and medicine. Its unique structural features make it a valuable tool for synthetic chemists and pharmacologists alike. As research continues to uncover new uses for this molecule, it is likely that its importance will only grow in the coming years.
83164-31-2 (2-tert-butylindolizine-3-carbaldehyde) Related Products
- 36944-76-0(1-(2-ethyl-3-indolizinyl)-Ethanone)
- 3243-75-2(1-(3-methyl-2-indolizinyl)-Ethanone)
- 24004-45-3(1-(2-methyl-3-indolizinyl)-Ethanone)
- 117068-04-9(1H-Pyrrole-2-carboxaldehyde,3-(1-methylpropyl)-)
- 32928-30-6(3-ethyl-4-methyl-1H-Pyrrole-2-carboxaldehyde)
- 324570-74-3(1H-Pyrrole-2-carboxaldehyde, 5-methyl-3-(1-methylethyl)- (9CI))
- 780800-74-0(3-(propan-2-yl)pyridine-2-carbaldehyde)
- 25365-67-7(2-Methylindolizine-3-carbaldehyde)
- 19711-71-8(4-ethyl-3-methyl-1H-Pyrrole-2-carboxaldehyde)
- 36944-65-7(1-(2,5-dimethyl-1-indolizinyl)-Ethanone)